News
Multiomics study identifies 18 potential MS targets, opening paths to drug discovery and repurposing
Multiple sclerosis (MS) is an immune-mediated inflammatory disease characterized by demyelination and degeneration in the ...
2d
AZoLifeSciences on MSNEvidence for Neural Stem Cell-Based Therapies in Multiple SclerosisResearch indicates that neural stem cell transplants could promote myelin repair in progressive multiple sclerosis, paving the way for innovative treatments.
Neuroprotection in Multiple Sclerosis Major impetus for studies on neuroprotection in MS was provided in the late 1990s by increased recognition of the frequency of axon degeneration in acute MS ...
Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis — and a new study suggests that supplementing it in high doses could help reduce symptoms.
These results indicate that white matter ECM proteoglycan alterations are integral to MS pathology at all disease stages and that they contribute to a CNS ECM that is inhospitable to axon ...
New data suggest the frequency of damage and repair processes correlates with disease severity and disability in multiple sclerosis (MS).
A study published in the Journal of Biological Chemistry found a plant-derived flavonoid—a type of chemical compound—called sulfuretin blocked the activity of an enzyme involved in MS and cancer.
Multiple Sclerosis diagnoses have been rising globally since 2013, and in 2019, an estimated 1 million people had MS. Doctors are trying to figure out why.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results